M C Del Canizo
Overview
Explore the profile of M C Del Canizo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diez Campelo M, Sanchez-Barba M, Gomez-Garcia de Soria V, Martino R, Sanz G, Insunza A, et al.
Leuk Res
. 2014 Aug;
38(10):1199-206.
PMID: 25139847
Although new agents have been approved for the treatment of MDS, the only curative approach is allogeneic hematopoietic stem cell transplantation (HSCT) and thus, in particular circumstances this procedure has...
2.
Matarraz S, Paiva B, Diez-Campelo M, Barrena S, Jara-Acevedo M, Gutierrez M, et al.
Leukemia
. 2014 Mar;
28(8):1747-50.
PMID: 24625552
No abstract available.
3.
Labrador J, Lopez-Corral L, Lopez-Godino O, Vazquez L, Cabrero-Calvo M, Perez-Lopez R, et al.
Bone Marrow Transplant
. 2014 Feb;
49(5):684-90.
PMID: 24566710
Transplantation-associated thrombotic microangiopathy (TA-TMA) is a feared complication of allogeneic hematopoietic SCT (HSCT) owing to its high mortality rate. The use of calcineurin inhibitors or sirolimus (SIR) for GVHD prophylaxis...
4.
Carrancio S, Romo C, Ramos T, Lopez-Holgado N, Muntion S, Prins H, et al.
Cell Transplant
. 2012 Oct;
22(7):1171-83.
PMID: 23031585
Hematopoietic stem cell transplantation (HSCT) using umbilical cord blood (UCB) progenitors is increasingly being used. One of the problems that may arise after UCB transplantation is an impaired engraftment. Either...
5.
Muntion S, Sanchez-Guijo F, Carrancio S, Villaron E, Lopez O, Diez-Campelo M, et al.
Transfus Med
. 2012 Feb;
22(2):122-7.
PMID: 22296109
Purpose: The aim of this study was to optimise the yield of metaphases in mesenchymal stromal cells (MSC) in vitro cultures and to study the karyotype of MSC expanded in...
6.
Villaron E, Almeida J, Lopez-Holgado N, Sanchez-Guijo F, Alberca M, Blanco B, et al.
Transfus Apher Sci
. 2007 Nov;
37(2):145-56.
PMID: 17983836
Damage to the stem cell progenitors caused by the chemotherapy received in patients diagnosed with non-Hodgkin's lymphoma (NHL) may be an important factor limiting progenitor cell mobilization. The aim of...
7.
Lopez-Holgado N, Alberca M, Sanchez-Guijo F, Villaron E, Almeida J, Martin A, et al.
Cytotherapy
. 2007 Mar;
9(1):14-22.
PMID: 17354099
Background: The aim of this study was to identify circulating endothelial progenitor cells (EPC) with colony-forming capacity and compare them with the monocytic-macrophage lineage. Methods: Forty-two healthy donors were analyzed....
8.
Hernandez J, Castilla C, Gutierrez N, Isidro I, Delgado M, De Las Rivas J, et al.
Leukemia
. 2005 Apr;
19(6):1088-91.
PMID: 15830010
No abstract available.
9.
Martin A, Perez-Simon J, Caballero M, Lopez N, Garcia-Sanz R, Vazquez L, et al.
Bone Marrow Transplant
. 2004 Jan;
33(6):579-87.
PMID: 14730338
Studies evaluating the effects of previous chemotherapy on stem-cell yield and hematological recovery after autologous peripheral-blood progenitor-cell transplantation (PBPCT) have shown conflicting results. We have retrospectively analyzed 103 consecutive lymphoma...
10.
Del Canizo M, Martinez C, Conde E, Vallejo C, Brunet S, Sanz G, et al.
Bone Marrow Transplant
. 2003 Nov;
32(10):987-92.
PMID: 14595386
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative therapy for patients with myelodysplastic syndromes (MDSs). We have analyzed the outcome of 81 patients who underwent an allogeneic transplant...